Could Metformin use reduce abdominal aortic aneurysm risk? A Mendelian randomisation study using known Metformin targets

Katie L Saxby, Frank Dudbridge, Nilesh J Samani, Matthew J Bown, Christopher P Nelson
doi: https://doi.org/10.1101/2023.10.13.23293381

Article Information

doi 
https://doi.org/10.1101/2023.10.13.23293381
History 
  • October 16, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Katie L Saxby, MSc1,*,
  2. Frank Dudbridge, PhD2,3,
  3. Nilesh J Samani, MD1,2,
  4. Matthew J Bown, MD1,2 and
  5. Christopher P Nelson, PhD1,2
  1. 1Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom
  2. 2NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, United Kingdom
  3. 3Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom
  1. ↵*Corresponding author:
    Katie L Saxby, kls46{at}leicester.ac.uk, Cardiovascular Research Centre, Glenfield Hospital, Groby Road, Leicester, LE3 9QP.
Back to top
Posted October 16, 2023.
Download PDF
Data/Code
Email
Could Metformin use reduce abdominal aortic aneurysm risk? A Mendelian randomisation study using known Metformin targets
Katie L Saxby, Frank Dudbridge, Nilesh J Samani, Matthew J Bown, Christopher P Nelson
medRxiv 2023.10.13.23293381; doi: https://doi.org/10.1101/2023.10.13.23293381
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area